Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  39,506 results for ""BEVACIZUMAB""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Quality of life in ovarian cancer patients treated with bevacizumab: a meta-analysis.

  • Authors : Wu D; Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.; Department of Pharmacy, Shanxi Yuncheng Central Hospital, Eighth Clinical Medical College of Shanxi Medical University, Yuncheng, China.

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/adverse effects ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Ovarian Neoplasms*/Ovarian Neoplasms*/Ovarian Neoplasms*/drug therapy

  • Source: Expert opinion on drug safety [Expert Opin Drug Saf] 2024 Mar; Vol. 23 (3), pp. 269-276. Date of Electronic Publication: 2023 Oct 24.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101163027 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical outcomes and medical resource utilization of toripalimab combination therapy versus bevacizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer.

  • Authors : Qi H; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China.; Zhang W

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: Current medical research and opinion [Curr Med Res Opin] 2024 Mar; Vol. 40 (3), pp. 441-453. Date of Electronic Publication: 2024 Jan 22.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate-stage hepatocellular carcinoma.

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/drug therapy

  • Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2024 Jan; Vol. 44 (1), pp. 113-124. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Characteristics of macular edema associated with retinal vein occlusion showing poor anatomic response to three loading anti-vascular endothelial growth factor injections: an optical coherence tomography analysis.

  • Authors : Johari M; Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Attar A

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/diagnosis ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/etiology

  • Source: BMC ophthalmology [BMC Ophthalmol] 2024 Jan 22; Vol. 24 (1), pp. 30. Date of Electronic Publication: 2024 Jan 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415

Record details

Read More Add to Saved list
×
Academic Journal

Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture.

  • Authors : Zaini A; Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.; Jawad HE

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/pharmacology ; Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Chemical and Drug Induced Liver Injury, Chronic*/Chemical and Drug Induced Liver Injury, Chronic*/Chemical and Drug Induced Liver Injury, Chronic*/complications

  • Source: Journal of medicine and life [J Med Life] 2023 Oct; Vol. 16 (10), pp. 1488-1498.Publisher:

Record details

Read More Add to Saved list
×
Academic Journal

Use of bevacizumab in a patient with Whipple's disease: managing diagnostic uncertainty.

  • Authors : Tjandra DP; Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia.; Brett A

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Whipple Disease*/Whipple Disease*/Whipple Disease*/drug therapy ; Whipple Disease*/Whipple Disease*/Whipple Disease*/pathology

  • Source: BMJ case reports [BMJ Case Rep] 2023 Oct 24; Vol. 16 (10). Date of Electronic Publication: 2023 Oct 24.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

Read More Add to Saved list
×
Report

Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report.

  • Authors : Li J; Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Zhang F

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/adverse effects ; Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/chemically induced ; Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/Arrhythmias, Cardiac*/diagnosis

  • Source: Medicine [Medicine (Baltimore)] 2023 Sep 01; Vol. 102 (35), pp. e34799.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer.

  • Authors : Marisi G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Azzali I

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Aug 09; Vol. 13 (1), pp. 12921. Date of Electronic Publication: 2023 Aug 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin ® in healthy Chinese male subjects.

  • Authors : Li H; National Institute of Clinical Drug Trials, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.; Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/pharmacokinetics ; Bevacizumab*/Bevacizumab*/Bevacizumab*/pharmacokinetics ; Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/Biosimilar Pharmaceuticals*/pharmacokinetics

  • Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2023 May 27; Vol. 24 (1), pp. 36. Date of Electronic Publication: 2023 May 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511

Record details

Read More Add to Saved list
×
Academic Journal

Antiangiogenic Therapeutic mRNA Delivery Using Lung-Selective Polymeric Nanomedicine for Lung Cancer Treatment.

  • Authors : Le ND; College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.; Nguyen BL

Subjects: Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

  • Source: ACS nano [ACS Nano] 2024 Mar 19; Vol. 18 (11), pp. 8392-8410. Date of Electronic Publication: 2024 Mar 07.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  39,506 results for ""BEVACIZUMAB""